Global CIS Insulin Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Jan, 2019
|
Report ID: 46790
|
123
|
Pharmaceuticals and Healthcare
Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body.
Scope of the Report:
This report studies the CIS Insulin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CIS Insulin market by product type and applications/end industries.
Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government.
The global CIS Insulin market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CIS Insulin.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Eli Lilly
Novo Nordisk
Takeda Pharmaceuticals
Sanofi Aventis
Nanjing Xinbai Pharmaceutical
Oramed Pharmaceuticals
Merck
Boehringer Ingelheim
Biocon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
Market Segment by Applications, can be divided into
Type I and Other Diabetes
Type II Diabetes
Scope of the Report:
This report studies the CIS Insulin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CIS Insulin market by product type and applications/end industries.
Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government.
The global CIS Insulin market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CIS Insulin.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Eli Lilly
Novo Nordisk
Takeda Pharmaceuticals
Sanofi Aventis
Nanjing Xinbai Pharmaceutical
Oramed Pharmaceuticals
Merck
Boehringer Ingelheim
Biocon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
Market Segment by Applications, can be divided into
Type I and Other Diabetes
Type II Diabetes
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 CIS Insulin Market Overview
1.1 Product Overview and Scope of CIS Insulin
1.2 Classification of CIS Insulin by Types
1.2.1 Global CIS Insulin Revenue Comparison by Types (2017-2023)
1.2.2 Global CIS Insulin Revenue Market Share by Types in 2017
1.2.3 Long-Acting Analog
1.2.4 Rapid Acting Analog
1.2.5 Premixed Analog
1.2.6 Intermediate Insulin
1.2.7 Short Acting Insulin
1.2.8 Premixed Insulin
1.3 Global CIS Insulin Market by Application
1.3.1 Global CIS Insulin Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Type I and Other Diabetes
1.3.3 Type II Diabetes
1.4 Global CIS Insulin Market by Regions
1.4.1 Global CIS Insulin Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) CIS Insulin Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) CIS Insulin Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CIS Insulin Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) CIS Insulin Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CIS Insulin Status and Prospect (2013-2023)
1.5 Global Market Size of CIS Insulin (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 CIS Insulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 CIS Insulin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda Pharmaceuticals
2.3.1 Business Overview
2.3.2 CIS Insulin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Aventis
2.4.1 Business Overview
2.4.2 CIS Insulin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.5 Nanjing Xinbai Pharmaceutical
2.5.1 Business Overview
2.5.2 CIS Insulin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.6 Oramed Pharmaceuticals
2.6.1 Business Overview
2.6.2 CIS Insulin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 CIS Insulin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.2 CIS Insulin Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biocon
2.9.1 Business Overview
2.9.2 CIS Insulin Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biocon CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
3 Global CIS Insulin Market Competition, by Players
3.1 Global CIS Insulin Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 CIS Insulin Players Market Share
3.2.2 Top 10 CIS Insulin Players Market Share
3.3 Market Competition Trend
4 Global CIS Insulin Market Size by Regions
4.1 Global CIS Insulin Revenue and Market Share by Regions
4.2 North America CIS Insulin Revenue and Growth Rate (2013-2018)
4.3 Europe CIS Insulin Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific CIS Insulin Revenue and Growth Rate (2013-2018)
4.5 South America CIS Insulin Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa CIS Insulin Revenue and Growth Rate (2013-2018)
5 North America CIS Insulin Revenue by Countries
5.1 North America CIS Insulin Revenue by Countries (2013-2018)
5.2 USA CIS Insulin Revenue and Growth Rate (2013-2018)
5.3 Canada CIS Insulin Revenue and Growth Rate (2013-2018)
5.4 Mexico CIS Insulin Revenue and Growth Rate (2013-2018)
6 Europe CIS Insulin Revenue by Countries
6.1 Europe CIS Insulin Revenue by Countries (2013-2018)
6.2 Germany CIS Insulin Revenue and Growth Rate (2013-2018)
6.3 UK CIS Insulin Revenue and Growth Rate (2013-2018)
6.4 France CIS Insulin Revenue and Growth Rate (2013-2018)
6.5 Russia CIS Insulin Revenue and Growth Rate (2013-2018)
6.6 Italy CIS Insulin Revenue and Growth Rate (2013-2018)
7 Asia-Pacific CIS Insulin Revenue by Countries
7.1 Asia-Pacific CIS Insulin Revenue by Countries (2013-2018)
7.2 China CIS Insulin Revenue and Growth Rate (2013-2018)
7.3 Japan CIS Insulin Revenue and Growth Rate (2013-2018)
7.4 Korea CIS Insulin Revenue and Growth Rate (2013-2018)
7.5 India CIS Insulin Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia CIS Insulin Revenue and Growth Rate (2013-2018)
8 South America CIS Insulin Revenue by Countries
8.1 South America CIS Insulin Revenue by Countries (2013-2018)
8.2 Brazil CIS Insulin Revenue and Growth Rate (2013-2018)
8.3 Argentina CIS Insulin Revenue and Growth Rate (2013-2018)
8.4 Colombia CIS Insulin Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue CIS Insulin by Countries
9.1 Middle East and Africa CIS Insulin Revenue by Countries (2013-2018)
9.2 Saudi Arabia CIS Insulin Revenue and Growth Rate (2013-2018)
9.3 UAE CIS Insulin Revenue and Growth Rate (2013-2018)
9.4 Egypt CIS Insulin Revenue and Growth Rate (2013-2018)
9.5 Nigeria CIS Insulin Revenue and Growth Rate (2013-2018)
9.6 South Africa CIS Insulin Revenue and Growth Rate (2013-2018)
10 Global CIS Insulin Market Segment by Type
10.1 Global CIS Insulin Revenue and Market Share by Type (2013-2018)
10.2 Global CIS Insulin Market Forecast by Type (2018-2023)
10.3 Long-Acting Analog Revenue Growth Rate (2013-2023)
10.4 Rapid Acting Analog Revenue Growth Rate (2013-2023)
10.5 Premixed Analog Revenue Growth Rate (2013-2023)
10.6 Intermediate Insulin Revenue Growth Rate (2013-2023)
10.7 Short Acting Insulin Revenue Growth Rate (2013-2023)
10.8 Premixed Insulin Revenue Growth Rate (2013-2023)
11 Global CIS Insulin Market Segment by Application
11.1 Global CIS Insulin Revenue Market Share by Application (2013-2018)
11.2 CIS Insulin Market Forecast by Application (2018-2023)
11.3 Type I and Other Diabetes Revenue Growth (2013-2018)
11.4 Type II Diabetes Revenue Growth (2013-2018)
12 Global CIS Insulin Market Size Forecast (2018-2023)
12.1 Global CIS Insulin Market Size Forecast (2018-2023)
12.2 Global CIS Insulin Market Forecast by Regions (2018-2023)
12.3 North America CIS Insulin Revenue Market Forecast (2018-2023)
12.4 Europe CIS Insulin Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific CIS Insulin Revenue Market Forecast (2018-2023)
12.6 South America CIS Insulin Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa CIS Insulin Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 CIS Insulin Market Overview
1.1 Product Overview and Scope of CIS Insulin
1.2 Classification of CIS Insulin by Types
1.2.1 Global CIS Insulin Revenue Comparison by Types (2017-2023)
1.2.2 Global CIS Insulin Revenue Market Share by Types in 2017
1.2.3 Long-Acting Analog
1.2.4 Rapid Acting Analog
1.2.5 Premixed Analog
1.2.6 Intermediate Insulin
1.2.7 Short Acting Insulin
1.2.8 Premixed Insulin
1.3 Global CIS Insulin Market by Application
1.3.1 Global CIS Insulin Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Type I and Other Diabetes
1.3.3 Type II Diabetes
1.4 Global CIS Insulin Market by Regions
1.4.1 Global CIS Insulin Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) CIS Insulin Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) CIS Insulin Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CIS Insulin Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) CIS Insulin Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CIS Insulin Status and Prospect (2013-2023)
1.5 Global Market Size of CIS Insulin (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 CIS Insulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 CIS Insulin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda Pharmaceuticals
2.3.1 Business Overview
2.3.2 CIS Insulin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Aventis
2.4.1 Business Overview
2.4.2 CIS Insulin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.5 Nanjing Xinbai Pharmaceutical
2.5.1 Business Overview
2.5.2 CIS Insulin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.6 Oramed Pharmaceuticals
2.6.1 Business Overview
2.6.2 CIS Insulin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 CIS Insulin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.2 CIS Insulin Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biocon
2.9.1 Business Overview
2.9.2 CIS Insulin Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biocon CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
3 Global CIS Insulin Market Competition, by Players
3.1 Global CIS Insulin Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 CIS Insulin Players Market Share
3.2.2 Top 10 CIS Insulin Players Market Share
3.3 Market Competition Trend
4 Global CIS Insulin Market Size by Regions
4.1 Global CIS Insulin Revenue and Market Share by Regions
4.2 North America CIS Insulin Revenue and Growth Rate (2013-2018)
4.3 Europe CIS Insulin Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific CIS Insulin Revenue and Growth Rate (2013-2018)
4.5 South America CIS Insulin Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa CIS Insulin Revenue and Growth Rate (2013-2018)
5 North America CIS Insulin Revenue by Countries
5.1 North America CIS Insulin Revenue by Countries (2013-2018)
5.2 USA CIS Insulin Revenue and Growth Rate (2013-2018)
5.3 Canada CIS Insulin Revenue and Growth Rate (2013-2018)
5.4 Mexico CIS Insulin Revenue and Growth Rate (2013-2018)
6 Europe CIS Insulin Revenue by Countries
6.1 Europe CIS Insulin Revenue by Countries (2013-2018)
6.2 Germany CIS Insulin Revenue and Growth Rate (2013-2018)
6.3 UK CIS Insulin Revenue and Growth Rate (2013-2018)
6.4 France CIS Insulin Revenue and Growth Rate (2013-2018)
6.5 Russia CIS Insulin Revenue and Growth Rate (2013-2018)
6.6 Italy CIS Insulin Revenue and Growth Rate (2013-2018)
7 Asia-Pacific CIS Insulin Revenue by Countries
7.1 Asia-Pacific CIS Insulin Revenue by Countries (2013-2018)
7.2 China CIS Insulin Revenue and Growth Rate (2013-2018)
7.3 Japan CIS Insulin Revenue and Growth Rate (2013-2018)
7.4 Korea CIS Insulin Revenue and Growth Rate (2013-2018)
7.5 India CIS Insulin Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia CIS Insulin Revenue and Growth Rate (2013-2018)
8 South America CIS Insulin Revenue by Countries
8.1 South America CIS Insulin Revenue by Countries (2013-2018)
8.2 Brazil CIS Insulin Revenue and Growth Rate (2013-2018)
8.3 Argentina CIS Insulin Revenue and Growth Rate (2013-2018)
8.4 Colombia CIS Insulin Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue CIS Insulin by Countries
9.1 Middle East and Africa CIS Insulin Revenue by Countries (2013-2018)
9.2 Saudi Arabia CIS Insulin Revenue and Growth Rate (2013-2018)
9.3 UAE CIS Insulin Revenue and Growth Rate (2013-2018)
9.4 Egypt CIS Insulin Revenue and Growth Rate (2013-2018)
9.5 Nigeria CIS Insulin Revenue and Growth Rate (2013-2018)
9.6 South Africa CIS Insulin Revenue and Growth Rate (2013-2018)
10 Global CIS Insulin Market Segment by Type
10.1 Global CIS Insulin Revenue and Market Share by Type (2013-2018)
10.2 Global CIS Insulin Market Forecast by Type (2018-2023)
10.3 Long-Acting Analog Revenue Growth Rate (2013-2023)
10.4 Rapid Acting Analog Revenue Growth Rate (2013-2023)
10.5 Premixed Analog Revenue Growth Rate (2013-2023)
10.6 Intermediate Insulin Revenue Growth Rate (2013-2023)
10.7 Short Acting Insulin Revenue Growth Rate (2013-2023)
10.8 Premixed Insulin Revenue Growth Rate (2013-2023)
11 Global CIS Insulin Market Segment by Application
11.1 Global CIS Insulin Revenue Market Share by Application (2013-2018)
11.2 CIS Insulin Market Forecast by Application (2018-2023)
11.3 Type I and Other Diabetes Revenue Growth (2013-2018)
11.4 Type II Diabetes Revenue Growth (2013-2018)
12 Global CIS Insulin Market Size Forecast (2018-2023)
12.1 Global CIS Insulin Market Size Forecast (2018-2023)
12.2 Global CIS Insulin Market Forecast by Regions (2018-2023)
12.3 North America CIS Insulin Revenue Market Forecast (2018-2023)
12.4 Europe CIS Insulin Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific CIS Insulin Revenue Market Forecast (2018-2023)
12.6 South America CIS Insulin Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa CIS Insulin Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure CIS Insulin Picture
Table Product Specifications of CIS Insulin
Table Global CIS Insulin and Revenue (Million USD) Market Split by Product Type
Figure Global CIS Insulin Revenue Market Share by Types in 2017
Figure Long-Acting Analog Picture
Figure Rapid Acting Analog Picture
Figure Premixed Analog Picture
Figure Intermediate Insulin Picture
Figure Short Acting Insulin Picture
Figure Premixed Insulin Picture
Table Global CIS Insulin Revenue (Million USD) by Application (2013-2023)
Figure CIS Insulin Revenue Market Share by Applications in 2017
Figure Type I and Other Diabetes Picture
Figure Type II Diabetes Picture
Table Global Market CIS Insulin Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly CIS Insulin Type and Applications
Table Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk CIS Insulin Type and Applications
Table Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceuticals CIS Insulin Type and Applications
Table Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi Aventis CIS Insulin Type and Applications
Table Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Nanjing Xinbai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Nanjing Xinbai Pharmaceutical CIS Insulin Type and Applications
Table Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Oramed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Oramed Pharmaceuticals CIS Insulin Type and Applications
Table Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck CIS Insulin Type and Applications
Table Merck CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim CIS Insulin Type and Applications
Table Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon CIS Insulin Type and Applications
Table Biocon CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Global CIS Insulin Revenue (Million USD) by Players (2013-2018)
Table Global CIS Insulin Revenue Share by Players (2013-2018)
Figure Global CIS Insulin Revenue Share by Players in 2016
Figure Global CIS Insulin Revenue Share by Players in 2017
Figure Global Top 5 Players CIS Insulin Revenue Market Share in 2017
Figure Global Top 10 Players CIS Insulin Revenue Market Share in 2017
Figure Global CIS Insulin Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global CIS Insulin Revenue (Million USD) by Regions (2013-2018)
Table Global CIS Insulin Revenue Market Share by Regions (2013-2018)
Figure Global CIS Insulin Revenue Market Share by Regions (2013-2018)
Figure Global CIS Insulin Revenue Market Share by Regions in 2017
Figure North America CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Europe CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific CIS Insulin Revenue and Growth Rate (2013-2018)
Figure South America CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa CIS Insulin Revenue and Growth Rate (2013-2018)
Table North America CIS Insulin Revenue by Countries (2013-2018)
Table North America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure North America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure North America CIS Insulin Revenue Market Share by Countries in 2017
Figure USA CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Canada CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Mexico CIS Insulin Revenue and Growth Rate (2013-2018)
Table Europe CIS Insulin Revenue (Million USD) by Countries (2013-2018)
Figure Europe CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Europe CIS Insulin Revenue Market Share by Countries in 2017
Figure Germany CIS Insulin Revenue and Growth Rate (2013-2018)
Figure UK CIS Insulin Revenue and Growth Rate (2013-2018)
Figure France CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Russia CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Italy CIS Insulin Revenue and Growth Rate (2013-2018)
Table Asia-Pacific CIS Insulin Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific CIS Insulin Revenue Market Share by Countries in 2017
Figure China CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Japan CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Korea CIS Insulin Revenue and Growth Rate (2013-2018)
Figure India CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Southeast Asia CIS Insulin Revenue and Growth Rate (2013-2018)
Table South America CIS Insulin Revenue by Countries (2013-2018)
Table South America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure South America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure South America CIS Insulin Revenue Market Share by Countries in 2017
Figure Brazil CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Argentina CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Colombia CIS Insulin Revenue and Growth Rate (2013-2018)
Table Middle East and Africa CIS Insulin Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CIS Insulin Revenue Market Share by Countries in 2017
Figure Saudi Arabia CIS Insulin Revenue and Growth Rate (2013-2018)
Figure UAE CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Egypt CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Nigeria CIS Insulin Revenue and Growth Rate (2013-2018)
Figure South Africa CIS Insulin Revenue and Growth Rate (2013-2018)
Table Global CIS Insulin Revenue (Million USD) by Type (2013-2018)
Table Global CIS Insulin Revenue Share by Type (2013-2018)
Figure Global CIS Insulin Revenue Share by Type (2013-2018)
Figure Global CIS Insulin Revenue Share by Type in 2017
Table Global CIS Insulin Revenue Forecast by Type (2018-2023)
Figure Global CIS Insulin Market Share Forecast by Type (2018-2023)
Figure Global Long-Acting Analog Revenue Growth Rate (2013-2018)
Figure Global Rapid Acting Analog Revenue Growth Rate (2013-2018)
Figure Global Premixed Analog Revenue Growth Rate (2013-2018)
Figure Global Intermediate Insulin Revenue Growth Rate (2013-2018)
Figure Global Short Acting Insulin Revenue Growth Rate (2013-2018)
Figure Global Premixed Insulin Revenue Growth Rate (2013-2018)
Table Global CIS Insulin Revenue by Application (2013-2018)
Table Global CIS Insulin Revenue Share by Application (2013-2018)
Figure Global CIS Insulin Revenue Share by Application (2013-2018)
Figure Global CIS Insulin Revenue Share by Application in 2017
Table Global CIS Insulin Revenue Forecast by Application (2018-2023)
Figure Global CIS Insulin Market Share Forecast by Application (2018-2023)
Figure Global Type I and Other Diabetes Revenue Growth Rate (2013-2018)
Figure Global Type II Diabetes Revenue Growth Rate (2013-2018)
Figure Global CIS Insulin Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global CIS Insulin Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global CIS Insulin Revenue Market Share Forecast by Regions (2018-2023)
Figure North America CIS Insulin Revenue Market Forecast (2018-2023)
Figure Europe CIS Insulin Revenue Market Forecast (2018-2023)
Figure Asia-Pacific CIS Insulin Revenue Market Forecast (2018-2023)
Figure South America CIS Insulin Revenue Market Forecast (2018-2023)
Figure Middle East and Africa CIS Insulin Revenue Market Forecast (2018-2023)
Figure CIS Insulin Picture
Table Product Specifications of CIS Insulin
Table Global CIS Insulin and Revenue (Million USD) Market Split by Product Type
Figure Global CIS Insulin Revenue Market Share by Types in 2017
Figure Long-Acting Analog Picture
Figure Rapid Acting Analog Picture
Figure Premixed Analog Picture
Figure Intermediate Insulin Picture
Figure Short Acting Insulin Picture
Figure Premixed Insulin Picture
Table Global CIS Insulin Revenue (Million USD) by Application (2013-2023)
Figure CIS Insulin Revenue Market Share by Applications in 2017
Figure Type I and Other Diabetes Picture
Figure Type II Diabetes Picture
Table Global Market CIS Insulin Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global CIS Insulin Revenue (Million USD) and Growth Rate (2013-2023)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly CIS Insulin Type and Applications
Table Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk CIS Insulin Type and Applications
Table Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceuticals CIS Insulin Type and Applications
Table Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi Aventis CIS Insulin Type and Applications
Table Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Nanjing Xinbai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Nanjing Xinbai Pharmaceutical CIS Insulin Type and Applications
Table Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Oramed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Oramed Pharmaceuticals CIS Insulin Type and Applications
Table Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck CIS Insulin Type and Applications
Table Merck CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim CIS Insulin Type and Applications
Table Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon CIS Insulin Type and Applications
Table Biocon CIS Insulin Revenue, Gross Margin and Market Share (2016-2017)
Table Global CIS Insulin Revenue (Million USD) by Players (2013-2018)
Table Global CIS Insulin Revenue Share by Players (2013-2018)
Figure Global CIS Insulin Revenue Share by Players in 2016
Figure Global CIS Insulin Revenue Share by Players in 2017
Figure Global Top 5 Players CIS Insulin Revenue Market Share in 2017
Figure Global Top 10 Players CIS Insulin Revenue Market Share in 2017
Figure Global CIS Insulin Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global CIS Insulin Revenue (Million USD) by Regions (2013-2018)
Table Global CIS Insulin Revenue Market Share by Regions (2013-2018)
Figure Global CIS Insulin Revenue Market Share by Regions (2013-2018)
Figure Global CIS Insulin Revenue Market Share by Regions in 2017
Figure North America CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Europe CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific CIS Insulin Revenue and Growth Rate (2013-2018)
Figure South America CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa CIS Insulin Revenue and Growth Rate (2013-2018)
Table North America CIS Insulin Revenue by Countries (2013-2018)
Table North America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure North America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure North America CIS Insulin Revenue Market Share by Countries in 2017
Figure USA CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Canada CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Mexico CIS Insulin Revenue and Growth Rate (2013-2018)
Table Europe CIS Insulin Revenue (Million USD) by Countries (2013-2018)
Figure Europe CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Europe CIS Insulin Revenue Market Share by Countries in 2017
Figure Germany CIS Insulin Revenue and Growth Rate (2013-2018)
Figure UK CIS Insulin Revenue and Growth Rate (2013-2018)
Figure France CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Russia CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Italy CIS Insulin Revenue and Growth Rate (2013-2018)
Table Asia-Pacific CIS Insulin Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific CIS Insulin Revenue Market Share by Countries in 2017
Figure China CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Japan CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Korea CIS Insulin Revenue and Growth Rate (2013-2018)
Figure India CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Southeast Asia CIS Insulin Revenue and Growth Rate (2013-2018)
Table South America CIS Insulin Revenue by Countries (2013-2018)
Table South America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure South America CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure South America CIS Insulin Revenue Market Share by Countries in 2017
Figure Brazil CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Argentina CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Colombia CIS Insulin Revenue and Growth Rate (2013-2018)
Table Middle East and Africa CIS Insulin Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CIS Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CIS Insulin Revenue Market Share by Countries in 2017
Figure Saudi Arabia CIS Insulin Revenue and Growth Rate (2013-2018)
Figure UAE CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Egypt CIS Insulin Revenue and Growth Rate (2013-2018)
Figure Nigeria CIS Insulin Revenue and Growth Rate (2013-2018)
Figure South Africa CIS Insulin Revenue and Growth Rate (2013-2018)
Table Global CIS Insulin Revenue (Million USD) by Type (2013-2018)
Table Global CIS Insulin Revenue Share by Type (2013-2018)
Figure Global CIS Insulin Revenue Share by Type (2013-2018)
Figure Global CIS Insulin Revenue Share by Type in 2017
Table Global CIS Insulin Revenue Forecast by Type (2018-2023)
Figure Global CIS Insulin Market Share Forecast by Type (2018-2023)
Figure Global Long-Acting Analog Revenue Growth Rate (2013-2018)
Figure Global Rapid Acting Analog Revenue Growth Rate (2013-2018)
Figure Global Premixed Analog Revenue Growth Rate (2013-2018)
Figure Global Intermediate Insulin Revenue Growth Rate (2013-2018)
Figure Global Short Acting Insulin Revenue Growth Rate (2013-2018)
Figure Global Premixed Insulin Revenue Growth Rate (2013-2018)
Table Global CIS Insulin Revenue by Application (2013-2018)
Table Global CIS Insulin Revenue Share by Application (2013-2018)
Figure Global CIS Insulin Revenue Share by Application (2013-2018)
Figure Global CIS Insulin Revenue Share by Application in 2017
Table Global CIS Insulin Revenue Forecast by Application (2018-2023)
Figure Global CIS Insulin Market Share Forecast by Application (2018-2023)
Figure Global Type I and Other Diabetes Revenue Growth Rate (2013-2018)
Figure Global Type II Diabetes Revenue Growth Rate (2013-2018)
Figure Global CIS Insulin Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global CIS Insulin Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global CIS Insulin Revenue Market Share Forecast by Regions (2018-2023)
Figure North America CIS Insulin Revenue Market Forecast (2018-2023)
Figure Europe CIS Insulin Revenue Market Forecast (2018-2023)
Figure Asia-Pacific CIS Insulin Revenue Market Forecast (2018-2023)
Figure South America CIS Insulin Revenue Market Forecast (2018-2023)
Figure Middle East and Africa CIS Insulin Revenue Market Forecast (2018-2023)
